AbbVie's Rinvoq Succeeds Against The Odds In Phase II Lupus Trial

Advances To Pivotal Program

blocks with arrows pointing diagonally upwards, on blue background
Rinvoq Is Now Progressing To A Phase III Lupus Program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D